Tuberculosis (TB) Programme

Why it matters

Tuberculosis caused 1.23 million deaths in 2024 — the world’s leading cause of death from a single infectious agent — with 10.7 million people falling ill and more than 80% of cases and deaths in low- and middle-income countries (WHO, 2026). Drug-resistant disease exposes the access gap: only about 2 in 5 people with multidrug-resistant TB accessed treatment in 2024 (WHO, 2026). The opportunity is proven — TB efforts have saved roughly 83 million lives since 2000 — but about $22 billion a year is needed by 2027 to hit global targets (WHO, 2026).

InBasket AI keeps the full TB treatment journey on one continuous record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.

Designed with reference to recognized global, national, and clinical standards

This care area is designed with reference to a standards ecosystem, including global guidance, national protocols, specialty-society recommendations, interoperability standards, and programme reporting requirements where applicable:

• WHO definitions and reporting framework for tuberculosis (2013 revision)
• WHO guidance on treatment adherence and defaulter tracing for TB
• Stop TB Partnership / Global Fund TB programme indicators and implementation frameworks where adopted
• National TB programme registers, contact investigation, laboratory reporting, and treatment-outcome requirements
• National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
• HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted
• National programme registers, surveillance definitions, DHIS2 or equivalent reporting requirements, and donor-reporting mappings where adopted

Standards sources

These sources substantiate the standards named above. Implementation-specific national protocols are selected from official national or regional authorities during deployment.

1. [1]World Health Organization guidelines and publications
2. [2]The Global Fund
3. [3]Official national Ministry of Health protocols for the implementation setting — Implementation-specific: selected from the official national or regional authority during deployment.
4. [4]National programme registers, DHIS2 or equivalent reporting requirements — Implementation-specific programme registers and reporting rules are configured from official national systems where adopted.
5. [5]HL7 FHIR
6. [6]WHO ICD classifications
7. [7]LOINC
8. [8]SNOMED CT

Evidence sources

• WHO Tuberculosis (2026)